2017—2018年某医院ICU病房使用麻醉药品的合理性评估

doi:10.3969/j.issn.1006-5253.2020.02.003

摘要
图/表
参考文献
相关文章 (0)

全文: PDF (883 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的探究某医院ICU病房使用麻醉药品的合理性，为优化麻醉药品的管理和合理使用提供参考。方法查询2017—2018年ICU病房麻醉药品使用数据，通过用药频度(DDDs)、药品日均费用(DDC)和药品利用指数(DUI)评估麻醉药品使用合理性。结果共有8种麻醉药品的使用记录。DDDs前3位是芬太尼注射液(3 500.0)、瑞芬太尼注射液(900.0)、芬太尼透皮贴剂(480.0)。DDC前3位是可待因片(900.9元)、丙泊酚(662.0元)、布桂嗪注射液(604.1元)。DUI>1有3种：芬太尼注射液（6.29）、芬太尼透皮贴剂（1.18）、瑞芬太尼注射液（4.84）。ICU疾病中，肿瘤、意外损伤和脓毒血症，仍以芬太尼注射液用量最大。结论某医院ICU病房中部分麻醉药品的使用可能存在不合理，需进一步优化麻醉药品的管理以及合理使用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	叶颖颖
	郑丽娜
	谢晓丹

关键词 ：麻醉药品, 　ICU, 　合理性评估

Abstract：Objective To explore the rational evaluation of the use of narcotic drugs in ICU of a hospital, and to provide reference for the optimization of the management and rational use of narcotic drugs. Methods Data of the use of narcotic drugs in ICU from 2017 to 2018 were collected. The rationality of the use of narcotic drugs was evaluated by DDDs, DDC and DUI. Results There were records of using eight kinds of narcotic drugs. The top three DDDs were fentanyl injection (3 500.0), remifentanil injection (900.0) and fentanyl transdermal patch (480.0). The top three DDC were codeine tablets (900.9 yuan), propofol (662.0 yuan), and buguizine injection (604.1 yuan). There were 3 kinds of DUI>1: fentanyl injection (6.29), remifentanil injection（1.18) and fentanyl transdermal patch (4.84). Among the diseases in ICU, the dosage of fentanyl injection was still the largest for tumor, accidental injury and sepsis. Conclusion The use of some anesthetics in ICU of a hospital may be unreasonable, and the management and rational use of anesthetics need to be further optimized.

Key words： narcotic drug ICU rationality evaluation

收稿日期: 2019-07-17

通讯作者: 叶颖颖，Email：yy85ye@126.com

引用本文:

叶颖颖，郑丽娜，谢晓丹. 2017—2018年某医院ICU病房使用麻醉药品的合理性评估[J]. 中国医院统计, 2020, 27(2): 106-108.
Ye Yingying, Zheng Li′na, Xie Xiaodan. Rationality evaluation of using narcotic drugs in ICU of a hospital from 2017 to 2018. journal1, 2020, 27(2): 106-108.

链接本文:

http://manu58.magtech.com.cn/Jwk_zgyytj/CN/10.3969/j.issn.1006-5253.2020.02.003 或 http://manu58.magtech.com.cn/Jwk_zgyytj/CN/Y2020/V27/I2/106

［1］ZHU Y, WANG Y, DU B, et al. Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients A systematic review and metaanalysis［J］. Crit Care, 2017,21(1):206.

［2］吕小群,张军.我院2012—2014年住院患者麻醉药品使用分析［J］.中国药房,2016,27(5):590-593.

［3］RAAD M, JAIN A, NEUMAN B J, et al. Association of patientreported narcotic use with shortand longterm outcomes after adult spinal deformity surgery: multicenter study of 425 patients with 2year followup［J］. Spine (Phila Pa 1976), 2018,43(19):1340-1346.

［4］李爱香,张婕.我院ICU麻醉药品使用情况分析［J］.海峡药学,2017,29(5):225-227.

［5］刘全义,杨亮蕊,郑杨.我院2012—2017年住院患者麻醉药品使用情况分析［J］.中国当代医药,2019,26(4):195-199.

［6］MERCHAN C, ALTSHULER D, PAPADOPOULOS J. Methylnaltrexone versus naloxone for opioidinduced constipation in the medical intensive care unit［J］. Ann Pharmacother, 2017,51(3):203-208.

［7］张薇.以限定日剂量值为基础进行药物利用研究的影响因素分析［J］.中国全科医学,2010,13(25):2892-2894.

［8］宫曙光.比对6个版次的《新编药物学》看我国临床降压药物发展［J］.中国药房,2007,31(18):2467-2468.

［9］徐彤彤,许筱.我院住院病人麻醉药品使用情况分析［J］.海峡药学,2010,22(1):150-151.

［10］PUNTILLO K A, NAIDU R. Chronic pain disorders after critical illness and ICUacquired opioid dependence: two clinical conundra［J］. Curr Opin Crit Care, 2016,22(5):506-512.

［11］陆蕴华.医疗机构麻醉和精神药品管理中存在的问题及对策［J］.中国处方药,2019,17(1):46-47.

［12］张凤莲,于腾飞.“四查十对”对于药剂师的重要性［J］.中国实用医药,2009,4(35):264-265.